Lantus solostar 100 unit/ML 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7VL6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,018
Award facts
- Contract value 100% obligated
- $2,018.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 28, 2026, for Lantus SoloStar 100 Unit/mL 3mL insulin pens, valued at $2,018.11. The award is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for global military healthcare programs.
The DLA Troop Support Medical IDC encompasses a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities supporting military treatment facilities and other federal healthcare systems worldwide. AmerisourceBergen's role as a prime vendor demonstrates the company's capability to meet federal procurement requirements for critical diabetes management medications and other essential pharmaceuticals. The contract reflects the Defense Logistics Agency's continued reliance on established prime vendor relationships to ensure efficient and cost-effective delivery of essential medical supplies to military healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F7VL6?
SPE2DR26F7VL6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F7VL6 worth?
The government has obligated $2,018 on SPE2DR26F7VL6.
Is contract SPE2DR26F7VL6 an order under another contract?
Yes. SPE2DR26F7VL6 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VL6 competed?
The extent of competition for SPE2DR26F7VL6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award